Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Lowe syndrome: a single center's experience in Korea

  • Kim, Hyun-Kyung (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Kim, Ja Hye (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Kim, Yoo-Mi (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Kim, Gu-Hwan (Department of Medical Genetics Center, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Lee, Beom Hee (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Choi, Jin-Ho (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Yoo, Han-Wook (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
  • Received : 2013.09.01
  • Accepted : 2013.10.16
  • Published : 2014.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Lowe syndrome is a rare, X-linked recessive disorder caused by mutations in the OCRL gene. It involves multiple anatomic systems, particularly the eyes, central nervous system, and kidneys, and leads to profound growth failure and global developmental delay. This study evaluated the clinical and genetic characteristics of Korean patients with Lowe syndrome. Methods: The clinical findings and results of genetic studies were reviewed for 12 male patients diagnosed with Lowe syndrome at a single medical institution. Results: The mean age of the patients at presentation was 2.2 months (range, 0-4 months), although the diagnosis was delayed by a mean of 2.8 years (range, 0-9.7 years). The mean follow-up period was 9.0 years (range, 0.6-16.7 years). Nine mutations in OCRL were identified in 11 patients (92%), with three novel mutations. The main presentation was congenital cataract in both eyes necessitating early cataract removal in the 11 patients with impaired visual acuity. Profound short stature and developmental delay were observed in all patients, and seizures occurred in 50% of the patients. All patients suffered from proximal renal tubular dysfunction, and one patient developed chronic renal failure. Other manifestations included pathologic fracture (50%), cutaneous cysts (42%), and cryptorchidism (42%). However, there was no bleeding tendency, and none of the patients died during the study period. Conclusion: This study describes the clinical and genetic characteristics of Korean patients with Lowe syndrome. The observations are helpful for understanding the natural courses of Lowe syndrome and for appropriate genetic counseling.

Keywords

References

  1. Loi M. Lowe syndrome. Orphanet J Rare Dis 2006;1:16. https://doi.org/10.1186/1750-1172-1-16
  2. Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Poussou RV, et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 2011;32:379-88. https://doi.org/10.1002/humu.21391
  3. Erdogan F, Ismailogullari S, Soyuer I, Ferahbas A, Poyrazoglu H. Different seizure types and skin lesions in oculocerebrorenal syndrome of Lowe. J Child Neurol 2007;22:427-31. https://doi.org/10.1177/0883073807301928
  4. Bockenhauer D, Bokenkamp A, van't Hoff W, Levtchenko E, Kistvan Holthe JE, Tasic V, et al. Renal phenotype in Lowe syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol 2008;3:1430-6. https://doi.org/10.2215/CJN.00520108
  5. Rodrigues Santos MT, Watanabe MM, Manzano FS, Lopes CH, Masiero D. Oculocerebrorenal Lowe syndrome: a literature review and two case reports. Spec Care Dentist 2007;27:108-11. https://doi.org/10.1111/j.1754-4505.2007.tb01750.x
  6. Won JH, Lee MJ, Park JS, Chung H, Kim JK, Shim JS. Multiple epidermal cysts in lowe syndrome. Ann Dermatol 2010;22:444-6. https://doi.org/10.5021/ad.2010.22.4.444
  7. Maia ML, do Val ML, Genzani CP, Fernandes FA, de Andrade MC, Carvalhaes JT. Lowe syndrome: report of five cases. J Bras Nefrol 2010;32:216-22. https://doi.org/10.1590/S0101-28002010000200011
  8. Silver DN, Lewis RA, Nussbaum RL. Mapping the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphisms. J Clin Invest 1987;79:282-5. https://doi.org/10.1172/JCI112795
  9. Pirruccello M, De Camilli P. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem Sci 2012;37: 134-43. https://doi.org/10.1016/j.tibs.2012.01.002
  10. Lowe CU, Terrey M, MacLachlan EA. Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity. AMA Am J Dis Child 1952;83:164-84.
  11. Korea Centers for Disease Control and Prevention, Division of Chronic Disease Surveillance, Committee for the Development of Growth Standard for Korean Children and Adolescents; Korean Pediatric Society, Committee for School Health and Public Health Statistics. 2007 Korean children and adolescents growth standard (commentary for the development of 2007 growth chart). Cheongwon: Korea Centers for Disease Control and Prevention, Division of Chronic Disease Surveillance, 2007.
  12. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984;104:849-54. https://doi.org/10.1016/S0022-3476(84)80479-5
  13. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985;106:522-6. https://doi.org/10.1016/S0022-3476(85)80697-1
  14. Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med 1991;324:1318-25. https://doi.org/10.1056/NEJM199105093241904
  15. Tricot L, Yahiaoui Y, Teixeira L, Benabdallah L, Rothschild E, Juquel JP, et al. End-stage renal failure in Lowe syndrome. Nephrol Dial Transplant 2003;18:1923-5. https://doi.org/10.1093/ndt/gfg294
  16. Lasne D, Baujat G, Mirault T, Lunardi J, Grelac F, Egot M, et al. Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disorders. Br J Haematol 2010;150:685-8. https://doi.org/10.1111/j.1365-2141.2010.08304.x
  17. Bailey LC Jr, Olivos IM, Leahey AM, Attree OF, Okabe I, Lewis RA, et al. Characterization of a candidate gene for OCRL [abstract]. Am J Hum Genet 1992;51(Suppl):A4.
  18. Cho HY, Lee BH, Choi HJ, Ha IS, Choi Y, Cheong HI. Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol 2008; 23:243-9. https://doi.org/10.1007/s00467-007-0686-9
  19. Addis M, Loi M, Lepiani C, Cau M, Melis MA. OCRL mutation analysis in Italian patients with Lowe syndrome. Hum Mutat 2004; 23:524-5.
  20. Satre V, Monnier N, Berthoin F, Ayuso C, Joannard A, Jouk PS, et al. Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene. Am J Hum Genet 1999;65:68-76. https://doi.org/10.1086/302443
  21. Monnier N, Satre V, Lerouge E, Berthoin F, Lunardi J. OCRL1 mutation analysis in French Lowe syndrome patients: implications for molecular diagnosis strategy and genetic counseling. Hum Mutat 2000;16:157-65. https://doi.org/10.1002/1098-1004(200008)16:2<157::AID-HUMU8>3.0.CO;2-9
  22. Lin T, Orrison BM, Leahey AM, Suchy SF, Bernard DJ, Lewis RA, et al. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. Am J Hum Genet 1997;60:1384-8. https://doi.org/10.1086/515471
  23. Kawano T, Indo Y, Nakazato H, Shimadzu M, Matsuda I. Oculocerebrorenal syndrome of Lowe: three mutations in the OCRL1 gene derived from three patients with different phenotypes. Am J Med Genet 1998;77:348-55. https://doi.org/10.1002/(SICI)1096-8628(19980605)77:5<348::AID-AJMG2>3.0.CO;2-J
  24. Lowe M. Structure and function of the Lowe syndrome protein OCRL1. Traffic 2005;6:711-9. https://doi.org/10.1111/j.1600-0854.2005.00311.x
  25. Lin SY, Lee CN, Shih JC, Lin CH, Su YN. Two cases of Lowe syndrome presenting as increased fetal nuchal translucency. J Perinat Med 2011;39:483-5.
  26. Daskalakis G, Anastasakis E, Lyberopoulos E, Antsaklis A. Prenatal detection of congenital cataract in a fetus with Lowe syndrome. J Obstet Gynaecol 2010;30:409-10. https://doi.org/10.3109/01443611003698695
  27. Suchy SF, Lin T, Horwitz JA, O'Brien WE, Nussbaum RL. First report of prenatal biochemical diagnosis of Lowe syndrome. Prenat Diagn 1998;18:1117-21. https://doi.org/10.1002/(SICI)1097-0223(199811)18:11<1117::AID-PD413>3.0.CO;2-Q
  28. Hsu SY, Tsai IJ, Tsau YK. Comparison of growth in primary Fanconi syndrome and proximal renal tubular acidosis. Pediatr Nephrol 2005;20:460-4. https://doi.org/10.1007/s00467-004-1771-y
  29. Jefferson AB, Majerus PW. Properties of type II inositol polyphosphate 5-phosphatase. J Biol Chem 1995;270:9370-7. https://doi.org/10.1074/jbc.270.16.9370
  30. Bothwell SP, Chan E, Bernardini IM, Kuo YM, Gahl WA, Nussbaum RL. Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy. J Am Soc Nephrol 2011;22:443-8. https://doi.org/10.1681/ASN.2010050565
  31. Kim SW, Yu YS, Kim IO, Cheong HI, Hwang YS, Choi Y. Two cases of oculocerebrorenal syndrome of Lowe. Korean J Pediatr 1999;42:419-23.
  32. Chou YY, Chao SC, Chiou YY, Lin SJ. Identification of OCRL1 mutations in two Taiwanese Lowe syndrome patients. Acta Paediatr Taiwan 2005;46:226-9.
  33. Lin T, Orrison BM, Suchy SF, Lewis RA, Nussbaum RL. Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients. Mol Genet Metab 1998;64:58-61. https://doi.org/10.1006/mgme.1998.2687

Cited by

  1. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome vol.30, pp.6, 2014, https://doi.org/10.1007/s00467-014-3013-2
  2. Gonadotrophin abnormalities in an infant with Lowe syndrome vol.2017, pp.None, 2014, https://doi.org/10.1530/edm-17-0042
  3. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis vol.7, pp.None, 2014, https://doi.org/10.1038/s41598-017-01447-3
  4. Molecular Mechanisms of Syndromic Cryptorchidism: Data Synthesis of 50 Studies and Visualization of Gene-Disease Network vol.9, pp.None, 2018, https://doi.org/10.3389/fendo.2018.00425
  5. Lowe syndrome with extremely short stature: growth hormone deficiency may be the pathogeny vol.37, pp.3, 2014, https://doi.org/10.1080/08977194.2019.1669589
  6. Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project vol.107, pp.4, 2014, https://doi.org/10.1016/j.ajhg.2020.08.001